Richard Yen
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$6.5MFederal grants as PI11 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
11 awards · $6.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II Fibrinogen-coated albumin spheres to accelerate bone healing in older adults | $1.2M | FIBROPLATE INC |
| Sep 12, 2024 | NIH | SBIR Phase I Fibrinogen-coated albumin nanospheres for mitigation of irradiation-induced wound healing impairment in breast cancer patients. | $386K | FIBROPLATE INC |
| Sep 30, 2021 | NIH | SBIR Phase I Fibrinogen coated albumin spheres to accelerate bone healing in older adults. | $247K | FIBROPLATE INC |
| Sep 22, 2021 | NIH | SBIR Phase I Fibrinogen coated albumin spheres to accelerate bone healing in older adults. | $247K | FIBROPLATE INC |
| Jun 1, 2021 | NIH | SBIR Phase I A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness | $254K | FIBROPLATE INC |
| May 28, 2021 | NIH | SBIR Phase I A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness | $254K | FIBROPLATE INC |
| Apr 30, 2021 | NIH | SBIR Phase II A multivalent, easy-to-use product to mitigate and treat radiation exposure | $878K | FIBROPLATE INC |
| May 8, 2020 | NIH | SBIR Phase II A multivalent, easy-to-use product to mitigate and treat radiation exposure | $1.8M | FIBROPLATE INC |
| May 7, 2020 | NIH | SBIR Phase II A multivalent, easy-to-use product to mitigate and treat radiation exposure | $934K | FIBROPLATE INC |
| 2019 | NIH | SBIR Phase I A multivalent, easy-to-use product to mitigate and treat radiation exposure | $181K | FIBROPLATE INC |
| Dec 28, 2018 | NIH | SBIR Phase I A multivalent, easy-to-use product to mitigate and treat radiation exposure | $181K | FIBROPLATE INC |
Peer ranks
Federal funding#159
Awards as PI#106
Patents#273
Companies
- FIBROPLATE INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.